Proteins and Peptides
30 April 2013
FDA approves Kcentra for the urgent reversal of anticoagulation in adults with major bleeding29 April 2013
FDA Accepts Octapharma USA Biological License Application for octaplex® – an Investigational 4-Factor PCC28 April 2013
Derma Sciences Begins Screening Patients in Second Phase 3 Trial with DSC127 for Healing Diabetic Foot Ulcers25 April 2013
Ampio Pharmaceuticals Completes Enrollment in Run-In SPRING study of Ampion in Osteoarthritis of the Knee24 April 2013
Anterios, Inc., Announces Corporate Financing To Further Clinical Development Of Its Topical Botulinum Product17 April 2013
Santarus and Pharming Announce Submission of RUCONEST Biologics License Application to FDA17 April 2013
Are Erythropoietins still an attractive R&D goal?10 April 2013
Aeterna Zentaris and Ergomed Sign Co-Development and Profit Sharing Agreement for AEZS-108 in Endometrial CancerNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports